Antioxidant Property of Jobelyn as the Possible Mechanism Underlying its Anti-amnesic Activity in Rodents

Solomon Umukoro, Adaeze Ugbomah, Adegbuyi Aderibigbe, Adrian Omogbiya, Solomon Umukoro, Adaeze Ugbomah, Adegbuyi Aderibigbe, Adrian Omogbiya

Abstract

Introduction: Amnesia or loss of memory is the cardinal hallmark of Alzheimer's disease (AD), a progressive neurodegenerative disorder associated with ageing process. Although, AD had been discovered over a century ago, drugs which could cure or halt the progression of the disease are yet to see the light of the day. However, there has been a growing interest in the use of phytomedicines with multipronged mechanisms of action that could target various aspects of the pathologies of AD. Jobelyn (JB) is a potent antioxidant African polyherbal formulation with active components that have been acclaimed to show neuroprotection. This investigation was carried out to evaluate whether JB has anti-amnesic and antioxidant activities.

Methods: The alteration of alternation behavior in the Y-maze paradigm was utilized as the test for memory function in mice. The effect of JB on acetylcholinesterase (AChE) activity, malondialdehyde (MDA) level and the concentrations of glutathione (GSH) in the frontal cortex and hippocampus were assessed in rats as means of providing insight into the mechanism underlying its anti-amnesic activity. The animals were given JB (1, 2.5 or 5mg/kg, i.p.) daily for 7 days before the biochemical assays or test for memory functions were carried out.

Results: JB was found to produce a significant increase in the level of alternation behavior compared with the control, suggesting anti-amnesic activity. Also, JB reversed the memory impairment induced by scopolamine, which further indicates anti-amnesic property. Furthermore, JB demonstrated a significant inhibition of MDA formation in the frontal cortex and hippocampus of rats, indicating antioxidant property. In addition, it increased the defense armory of the brain tissues, as it significantly increased the concentrations of GSH in the frontal cortex and hippocampus of rats. However, JB did not demonstrate any inhibitory effect against AChE activity in the frontal cortex and hippocampus of rats in comparison with the control group.

Discussion: This investigation provides evidence that suggests that JB has anti-amnesic and antioxidant properties. Although the present data suggest that the anti-amnesic property of JB might be related to its antioxidant activity, more studies are necessary to clarify this observation.

Keywords: Anti-Amnesic; Antioxidant; Glutathione Concentrations; Jobelyn; Malondialdehyde Levels.

Figures

Figure 1
Figure 1
Effects of Jobelyn on memory performance in the Y-maze paradigm in mice. Values represent the mean ± S.E.M for 6 animals per group. *p

Figure 2

Effect of Jobelyn on scopolamine-induced…

Figure 2

Effect of Jobelyn on scopolamine-induced amnesia in mice. Values represent the mean ±…

Figure 2
Effect of Jobelyn on scopolamine-induced amnesia in mice. Values represent the mean ± S.E.M for 6 animals per group. *p

Figure 3

Effect of Jobelyn on the…

Figure 3

Effect of Jobelyn on the total number of entries in the Y-maze paradigm…

Figure 3
Effect of Jobelyn on the total number of entries in the Y-maze paradigm in mice. Values represent mean ± S.E.M for 6 animals per group. There are no significant (p > 0.05) differences in the total number of arm entries in treatment groups in comparism with the control group (ANOVA followed by Newman Keuls test).
Similar articles
Cited by
References
    1. Awika, J. M., & Rooney, L. W. (2004). Sorghum phytochemicals and their potential impact on human health. Phytochemistry, 65, 1199–1221 - PubMed
    1. Bejar, C., Wang, R. H., & Weinstock, M. (1999). Effect of rivastigmine on scopolamine induced memory impairment in rats. European Journal of Pharmacology, 383, 231–240 - PubMed
    1. Blokland, A. (2005). Scopolamine-induced deficits in cognitive performance: A review of animal studies. Scopolamine Review, 1–76
    1. Brito, G. N. O., Davis, B. J., Stopp, L. C., & Stanton, M. E. (1983). Memory and the septohippocampal cholinergic system in the rat. Psychopharmacology, 81, 315–320 - PubMed
    1. Casadesus, G., Webber, K. M., Atwood, C. S., Pappolla, M. A., Perry, G., Bowen, R. L., Smith, M. A. (2006). Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochimica Biophysica Acta, 1762, 447–452 - PubMed
Show all 32 references
Related information
LinkOut - more resources
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 2
Figure 2
Effect of Jobelyn on scopolamine-induced amnesia in mice. Values represent the mean ± S.E.M for 6 animals per group. *p

Figure 3

Effect of Jobelyn on the…

Figure 3

Effect of Jobelyn on the total number of entries in the Y-maze paradigm…

Figure 3
Effect of Jobelyn on the total number of entries in the Y-maze paradigm in mice. Values represent mean ± S.E.M for 6 animals per group. There are no significant (p > 0.05) differences in the total number of arm entries in treatment groups in comparism with the control group (ANOVA followed by Newman Keuls test).
Figure 3
Figure 3
Effect of Jobelyn on the total number of entries in the Y-maze paradigm in mice. Values represent mean ± S.E.M for 6 animals per group. There are no significant (p > 0.05) differences in the total number of arm entries in treatment groups in comparism with the control group (ANOVA followed by Newman Keuls test).

References

    1. Awika, J. M., & Rooney, L. W. (2004). Sorghum phytochemicals and their potential impact on human health. Phytochemistry, 65, 1199–1221
    1. Bejar, C., Wang, R. H., & Weinstock, M. (1999). Effect of rivastigmine on scopolamine induced memory impairment in rats. European Journal of Pharmacology, 383, 231–240
    1. Blokland, A. (2005). Scopolamine-induced deficits in cognitive performance: A review of animal studies. Scopolamine Review, 1–76
    1. Brito, G. N. O., Davis, B. J., Stopp, L. C., & Stanton, M. E. (1983). Memory and the septohippocampal cholinergic system in the rat. Psychopharmacology, 81, 315–320
    1. Casadesus, G., Webber, K. M., Atwood, C. S., Pappolla, M. A., Perry, G., Bowen, R. L., Smith, M. A. (2006). Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochimica Biophysica Acta, 1762, 447–452
    1. Coyle, T, & Puttfarcven, P. (1993). “Oxidative Stress, Glutamate and Neurodegenerative Disorder. Science,” 262, 89–695
    1. Dunning, J., & During, M. J. (2003). Molecular mechanisms of learning and memory. Expert Reviews in Molecular Medicine, 5(25), 1–11
    1. Ellman, G. L., Courtney, K. D., Andre, Jr. V., & Featherstone, R. M. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacology, 7, 88–95
    1. El-Sherbiny, D. A., Khalifa, A. E., Attia, A. S., & Eldenshary, E. E. S. (2003). Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacology Biochemistry & Behaviour, 76, 523–533
    1. Erah, P. O., Asonye, C. C., & Okhamafe, A. O. (2003). Response of Trypanosoma brucei–induced anaemia to a commercial herbal preparation. African Journal of Biotechnology, 2, 307–311
    1. Heo, H. J., Kim, M., Lee, J., Choi, S., Cho, H., Hong, B., Kim, H., Kim, E., & Shin, D. (2004). Naringenin from Citrus junos has an inhibitory effect on acetylcholinesterase and a mitigating effect on amnesia. Dementia and Geratric Cognitive Disorders, 17, 151–157
    1. Holttum, J. R., & Gershon, S. (1992). The cholinergic model of dementia, Alzheimer type: progression from the unitary transmitter concept. Dementia, 3, 174–185
    1. Hooper, N., Fraser, C., & Stone, T. (1996). Effects of purine analogues on spontaneous alternation in mice. Psychopharmacology, 123, 250–257
    1. Hsieh, M.T., Peng, W.H., Wu, C.R., Ng, K.Y., Cheng, C.L., & Xu, H.X. (2010). Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity. Planta Med., 76, 203–217
    1. Jimenez-Jimenez, F. J., Alonso-Navarro, H., Avuso-Peralta, L., & Jabbour-Wadih, T. (2006). Oxidative stress and Alzheimer's disease. Review Neurol., 42, 419–427
    1. Kamal, M.N., Greig, H.N, & Reale, M. (2009). Anti-Inflammatory Properties of Acetylcholinesterase Inhibitors Administred in Alzheimer's Disease. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 8, 85–100
    1. Lee, M., Yun, B., Zhang, D., Liu, L., Wang, Z., Wang, C., Gu, L., Wang, C., Mo, E., Ly, S., & Sung, C. (2010). Effect of aqueous antler extract on scopolamine induced memory impairment in mice and antioxidant activities. Food Sci. Biotechnol., 19, 655–661
    1. Liu, R., Gao, M., Qiang, G-F., Zhang, T-T., Lan, X., Ying, J., & Du, G-H. (2009). The anti-amnesic effects of luteolin against amyloid β25–35 peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience, 162, 1232–1243
    1. Lovell, M. A., Ehmann, W. D., Butler, S. M., Markesbery, W. R. (1995). Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology, 45, 1594–1601
    1. Markesbery, W. R. (1997). Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology and Medicine, 23(1), 134–147
    1. Ming, T. H., Wen, H. P., Chi, R. W., Kit, Y. N., Chuen, L. C., & Hong, X. X. (2010). Review on Experimental Research of Herbal Medicines with Anti-Amnesic Activity. Planta Med, 76, 203–217
    1. Moreira, P. I., Santos, M. S., Oliveira, C. R., Shenk, J. C., Nunomura, A., Smith, M. A., Zhu, X., & Perry, G. (2008). Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurological Disorders and Drug Target, 7(1), 3–10
    1. Moron, M. S., Depierre, J. W., & Mannervik, B. (1979). Levels of glutathione, glutathione reductase and glutathione Stransferase activities in rat lung and liver. Biochimica et Biophysica ACTA, 582, 67–78
    1. Myhrer, T. (2003). Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Research Review, 41, 268–287
    1. Natalie, A., Kelsey, I., Heather, M., Wilkins, I., & Linseman, D. A. (2010). Nutraceutical Antioxidants as novel neuroprotective agents. Molecules, 15, 7792–7814
    1. Ohkawa, H., Ohishi, N., & Yagi, K. (1979). “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, 95(2), 351–358
    1. Okochi, V. I., Okpuzor, J., Okubena, M. O., & Awoyemi, A. K. (2003). The influence of African Herbal Formula on the haematological parameters of trypanosome infected rats. African Journal of Biotechnology, 2, 312–316
    1. Schulz, J.B., Linderau, J., & Dichgans, J. L. (2000). Glutathione, Oxidative Stress and Neurodegeneration. European Journal of Biochemistry, Vol. 267, No.16, pp. 4904–4911
    1. Tabet, N., Mantle, D., & Orrell, M. (2000). Free radicals as mediators of toxicity in Alzheimer's disease: a review and hypothesis. Adverse Drug Reaction and Toxicol Review, 19(2), 127–152
    1. Taylor, P. (2001). Anticholinerasterase agents. In Hardman J.B, Limbird L.E, & Gilman A. (Ed.), The Goodman and Gilman's Pharmacological Basis of Therapeutics, (pp. 175–191). McGraw-Hill: New York
    1. Yan, J., Cho, J., Kim, H., Jung, J., Huh, S., Suh, H., & Song, D. (2001). Protection against β-amyloid peptide toxicity in vivo with long term administration of ferulic acid. British Journal of pharmacology, 133, 89–96
    1. Zhang, H. T., & O'Donnell, J. M. (2000). Effects of rolipram on scopolamine-induced impairment of working and reference memory in the radial-arm maze tests in rats. Psychopharmacology, 150, 311–316

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する